Religare Enterprises Limited has informed the Exchange regarding 'Investment in material Subsidiary of the Company'.
RELIGARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and in line with its Investment Company peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Religare Enterprises Limited (REL) has invested approximately ₹256.10 crores in its health insurance subsidiary, Care Health Insurance Ltd. (CHIL), by subscribing to its rights issue. REL was allotted 1,71,83,545 equity shares of face value ₹10 each at a premium of ₹139.04 per share. The Board of REL approved the subscription on September 18, 2025, and the allotment was completed on September 29, 2025. CHIL, which is Religare's material unlisted subsidiary, has 270 branches, over 11,000 professionals, and serves more than 3 million policyholders. The proceeds raised by CHIL will be used to fund its business expansion plans and to meet statutory solvency requirements. The transaction was carried out in cash at arm's length terms offered uniformly to all shareholders.
This is a significant capital infusion into Religare's health insurance arm, reinforcing CHIL's solvency position and supporting its growth. For shareholders, this means additional capital is being deployed into the insurance vertical, which should strengthen the long-term value of the subsidiary, though it represents cash outflow from the holding company with no immediate return.